177 results on '"Song, Minkyo"'
Search Results
2. Family history and gastric cancer incidence and mortality in Asia: a pooled analysis of more than half a million participants
- Author
-
Huang, Dan, Song, Minkyo, Abe, Sarah Krull, Rahman, Md. Shafiur, Islam, Md. Rashedul, Saito, Eiko, De la Torre, Katherine, Sawada, Norie, Tamakoshi, Akiko, Shu, Xiao-Ou, Cai, Hui, Hozawa, Atsushi, Kanemura, Seiki, Kim, Jeongseon, Chen, Yu, Ito, Hidemi, Sugawara, Yumi, Park, Sue K., Shin, Myung-Hee, Hirabayashi, Mayo, Kimura, Takashi, Gao, Yu-Tang, Wen, Wanqing, Oze, Isao, Shin, Aesun, Ahn, Yoon-Ok, Ahsan, Habibul, Boffetta, Paolo, Chia, Kee Seng, Matsuo, Keitaro, Qiao, You-Lin, Rothman, Nathaniel, Zheng, Wei, Inoue, Manami, and Kang, Daehee
- Published
- 2024
- Full Text
- View/download PDF
3. Reproductive factors, hormonal interventions, and gastric cancer risk in the Stomach cancer Pooling (StoP) Project
- Author
-
Song, Minkyo, Jayasekara, Harindra, Pelucchi, Claudio, Rabkin, Charles S., Johnson, Kenneth C., Hu, Jinfu, Palli, Domenico, Ferraroni, Monica, Liao, Linda M., Bonzi, Rossella, Zaridze, David, Maximovitch, Dmitry, Aragonés, Nuria, Martin, Vicente, Castaño-Vinyals, Gemma, Guevara, Marcela, Tsugane, Shoichiro, Hamada, Gerson Shigueaki, Hidaka, Akihisa, Negri, Eva, Ward, Mary H., Sinha, Rashmi, Lagiou, Areti, Lagiou, Pagona, Boffetta, Paolo, Curado, Maria Paula, Lunet, Nuno, Vioque, Jesus, Zhang, Zuo-Feng, La Vecchia, Carlo, and Camargo, M. Constanza
- Published
- 2024
- Full Text
- View/download PDF
4. Plasma proteomic biomarkers and the association between poor cardiovascular health and incident dementia: The UK Biobank study
- Author
-
Beydoun, May A., Beydoun, Hind A., Hu, Yi-Han, Maino Vieytes, Christian A., Noren Hooten, Nicole, Song, Minkyo, Georgescu, Michael F., Fanelli-Kuczmarski, Marie T., Meirelles, Osorio, Launer, Lenore J., Evans, Michele K., and Zonderman, Alan B.
- Published
- 2024
- Full Text
- View/download PDF
5. Identification of anti-Helicobacter pylori antibody signatures in gastric intestinal metaplasia
- Author
-
Song, Lusheng, Song, Minkyo, Rabkin, Charles S., Chung, Yunro, Williams, Stacy, Torres, Javier, Corvalan, Alejandro H., Gonzalez, Robinson, Bellolio, Enrique, Shome, Mahasish, LaBaer, Joshua, Qiu, Ji, and Camargo, M. Constanza
- Published
- 2023
- Full Text
- View/download PDF
6. Association between long-term exposure to particulate matter and childhood cancer: A retrospective cohort study
- Author
-
Lee, Jae Min, Lee, Tae-Hee, Kim, Soontae, Song, Minkyo, and Bae, Sanghyuk
- Published
- 2022
- Full Text
- View/download PDF
7. Associations between eosinophils and cancer risk in the UK Biobank.
- Author
-
Wang, Jeanny H., Rabkin, Charles S., Engels, Eric A., and Song, Minkyo
- Subjects
DISEASE risk factors ,EOSINOPHILS ,CHRONIC leukemia ,DIFFUSE large B-cell lymphomas ,LEUKOCYTE count ,INTRAHEPATIC bile ducts ,CHOLANGIOCARCINOMA - Abstract
Eosinophils exhibit anti‐tumor cytotoxic responses in the tumor microenvironment and may contribute to tumor immunosurveillance. To assess the relationship between circulating eosinophils and cancer risk, we analyzed data from 443,542 adults aged 38–73 in the UK Biobank, who were initially cancer‐free, had over a year of follow‐up, and baseline white blood cell count measurements. Using multivariable Cox regression, we estimated hazard ratios (aHR) and 95% confidence intervals (95%CI) for each quartile increase in absolute eosinophil count (AEC) across 58 cancer types, adjusting for relevant confounders. During a median follow‐up of 5.8 years, 22,747 incident cancer cases were diagnosed. We observed an inverse association, which met Bonferroni significance, between AEC and overall cancer risk (aHR, 95%CI 0.97, 0.95–0.98). Notably, 16 cancer types showed borderline associations (p <.05) with AEC, with 12 types displaying an inverse relationship. These included four hematologic cancers (acute and other myeloid leukemia, other lymphocytic leukemia, and chronic lymphocytic leukemia/small lymphocytic lymphoma; aHR range; 0.58–0.87) and eight nonhematologic cancers (melanoma and nose/middle ear, soft tissue/heart, gum/other mouth, tongue, lung, colon, and breast cancers; aHR range: 0.65–0.95). Higher AEC showed a borderline significant association with increased risk for intrahepatic bile duct cancer, Hodgkin lymphoma, diffuse large B‐cell lymphoma, and chronic myeloid leukemia (aHR range: 1.13–1.42). Our study, the largest to date, provides insights into the relationship between blood eosinophils and a comprehensive list of incident cancers. The inverse association between AEC and overall cancer risk suggests a protective role for eosinophils in tumor surveillance. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. Associations of circulating mediators of inflammation, cell regulation and immune response with esophageal squamous cell carcinoma
- Author
-
Camargo, M. Constanza, Song, Minkyo, Ito, Hidemi, Oze, Isao, Koyanagi, Yuriko N., Kasugai, Yumiko, Rabkin, Charles S., and Matsuo, Keitaro
- Published
- 2021
- Full Text
- View/download PDF
9. Identification of anti-Epstein-Barr virus (EBV) antibody signature in EBV-associated gastric carcinoma
- Author
-
Song, Lusheng, Song, Minkyo, Camargo, M. Constanza, Van Duine, Jennifer, Williams, Stacy, Chung, Yunro, Kim, Kyoung-Mee, Lissowska, Jolanta, Sivins, Armands, Gao, Weimin, Karthikeyan, Kailash, Park, Jin, Leja, Marcis, Cohen, Jeffrey I., LaBaer, Joshua, Qiu, Ji, and Rabkin, Charles S.
- Published
- 2021
- Full Text
- View/download PDF
10. Low Epstein–Barr Virus Prevalence in Cardia Gastric Cancer Among a High-Incidence Chinese Population
- Author
-
Aversa, John G., Song, Minkyo, Hu, Nan, Goldstein, Alisa M., Hewitt, Stephen M., Gulley, Margaret L., Dawsey, Sanford, Camargo, Maria Constanza, Taylor, Philip R., and Rabkin, Charles S.
- Published
- 2021
- Full Text
- View/download PDF
11. Diabetes and gastric cancer incidence and mortality in the Asia Cohort Consortium: A pooled analysis of more than a half million participants.
- Author
-
De la Torre, Katherine, Song, Minkyo, Abe, Sarah Krull, Rahman, Md. Shafiur, Islam, Md. Rashedul, Saito, Eiko, Min, Sukhong, Huang, Dan, Chen, Yu, Gupta, Prakash C., Sawada, Norie, Tamakoshi, Akiko, Shu, Xiao‐Ou, Wen, Wanqing, Sakata, Ritsu, Kim, Jeongseon, Nagata, Chisato, Ito, Hidemi, Park, Sue K., and Shin, Myung‐Hee
- Subjects
- *
STOMACH cancer , *CANCER-related mortality , *PROPORTIONAL hazards models , *DIABETES , *ASIANS , *HELICOBACTER pylori infections - Abstract
Background: Evidence suggests a possible link between diabetes and gastric cancer risk, but the findings remain inconclusive, with limited studies in the Asian population. We aimed to assess the impact of diabetes and diabetes duration on the development of gastric cancer overall, by anatomical and histological subtypes. Methods: A pooled analysis was conducted using 12 prospective studies included in the Asia Cohort Consortium. Among 558 981 participants (median age 52), after a median follow‐up of 14.9 years and 10.5 years, 8556 incident primary gastric cancers and 8058 gastric cancer deaths occurred, respectively. Cox proportional hazard regression models were used to estimate study‐specific hazard ratios (HRs) and 95% confidence intervals (CIs) and pooled using random‐effects meta‐analyses. Results: Diabetes was associated with an increased incidence of overall gastric cancer (HR 1.15, 95% CI 1.06–1.25). The risk association did not differ significantly by sex (women vs men: HR 1.31, 95% CI 1.07–1.60 vs 1.12, 1.01–1.23), anatomical subsites (noncardia vs cardia: 1.14, 1.02–1.28 vs 1.17, 0.77–1.78) and histological subtypes (intestinal vs diffuse: 1.22, 1.02–1.46 vs 1.00, 0.62–1.61). Gastric cancer risk increased significantly during the first decade following diabetes diagnosis (HR 4.70, 95% CI 3.77–5.86), and decreased with time (nonlinear p <.01). Positive associations between diabetes and gastric cancer mortality were observed (HR 1.15, 95% CI 1.03–1.28) but attenuated after a 2‐year time lag. Conclusion: Diabetes was associated with an increased gastric cancer incidence regardless of sex, anatomical subsite, or subtypes of gastric cancer. The risk of gastric cancer was particularly high during the first decade following diabetes diagnosis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
12. Neutrophil-to-lymphocyte ratio and mortality in the United States general population
- Author
-
Song, Minkyo, Graubard, Barry I., Rabkin, Charles S., and Engels, Eric A.
- Published
- 2021
- Full Text
- View/download PDF
13. Autoimmune disease and the risk of anal cancer in the US population aged 66 years and over.
- Author
-
Song, Minkyo, Engels, Eric A, Clarke, Megan A, Kreimer, Aimée R, and Shiels, Meredith S
- Subjects
- *
ANAL cancer , *AUTOIMMUNE diseases , *ANAL diseases , *DISEASE risk factors , *SQUAMOUS cell carcinoma , *SYSTEMIC lupus erythematosus - Abstract
Background In the United States, anal squamous cell carcinoma rates have increased rapidly, particularly among women 50 or older than 66 years of age. As immunosuppression is associated with increased risk, autoimmune conditions may be associated with greater risk of anal squamous cell carcinoma. Methods We conducted a population-based, case-control study using Surveillance, Epidemiology, and End Results–Medicare data (2000-2017). Anal squamous cell carcinoma cases (n = 4505) were matched to 200 000 cancer-free controls. Using multivariable logistic regression, we calculated odds ratios (ORs) and 95% confidence intervals (CIs) for associations between 47 autoimmune conditions diagnosed before selection, identified using Medicare claims, and anal squamous cell carcinoma. The Bonferroni threshold was used to correct for multiple comparisons. Population attributable fractions were calculated for conditions nominally associated with anal squamous cell carcinoma. Results In total, 18% of anal squamous cell carcinoma cases and 15% of cancer-free controls had a diagnosed autoimmune condition. Any autoimmune condition was associated with an increased risk of anal squamous cell carcinoma (OR = 1.11, 95% CI = 1.02 to 1.21; population attributable fraction = 1.8%). Anal squamous cell carcinoma was associated with systemic lupus erythematosus (OR = 1.79, 95% CI = 1.32 to 2.42; population attributable fraction = 0.4%) and nominally associated (P < .05) with sarcoidosis (OR = 2.09, 95% CI = 1.30 to 3.37; population-attributable fraction = 0.2%) and psoriasis (OR = 1.28, 95% CI = 1.06 to 1.56; population attributable fraction = 0.5%). Stratified by sex, only women showed statistically significant associations for systemic lupus erythematosus (OR = 1.97, 95% CI = 1.46 to 2.68). Statistically significant interaction was observed by sex for psoriasis (men vs women: OR = 1.68 [95% CI = 1.03 to 4.28] vs OR = 1.12 [95% CI = 0.88 to 1.43]) and polymyalgia rheumatica (OR = 0.33 [95% CI = 0.12 to 0.89] vs OR = 0.99 [95% CI = 0.75 to 1.30]). Conclusion Systemic lupus erythematosus, sarcoidosis, and psoriasis were associated with a moderately increased risk of anal squamous cell carcinoma. Given these conditions' rarity and moderate associations with anal squamous cell carcinoma, autoimmune diseases cannot explain the rising trend in this disease. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
14. Gastric Cancer: an Evolving Disease
- Author
-
Song, Minkyo, Rabkin, Charles S., and Camargo, M. Constanza
- Published
- 2018
- Full Text
- View/download PDF
15. Family history of cancer in first-degree relatives and risk of gastric cancer and its precursors in a Western population
- Author
-
Song, Minkyo, Camargo, M. Constanza, Weinstein, Stephanie J., Best, Ana F., Männistö, Satu, Albanes, Demetrius, and Rabkin, Charles S.
- Published
- 2018
- Full Text
- View/download PDF
16. Impact of overweight and obesity on US renal cell carcinoma incidence trends (1995‐2018).
- Author
-
Luo, Qianlai, Hofmann, Jonathan N., Pfeiffer, Ruth M., Kitahara, Cari M., Song, Minkyo, and Shiels, Meredith S.
- Subjects
RENAL cell carcinoma ,OBESITY ,OLDER people ,BODY mass index - Abstract
In the United States, renal cell carcinoma (RCC) incidence and the prevalence of obesity, an established risk factor for RCC, have been increasing for several decades. RCC is more common among older individuals. We sought to quantify the contribution of excess adiposity to the rising incidence of RCC among individuals 60 years or older. National Institutes of Health‐American Association of Retired Persons Diet and Health Study data (n = 453 859 participants, enrolled in 1995‐1996, age at enrollment 50‐71 years) were used to estimate multivariable‐adjusted hazard ratios (HRs) for RCC across body mass index categories and HRs associated with smoking. Population attributable fractions (PAFs) were calculated using estimated HRs and annual overweight/obesity prevalence from the National Health Interview Survey (1985‐2008). PAF estimates were combined with RCC incidence from Surveillance, Epidemiology and End Results‐13 to calculate annual percent changes in RCC incidence attributable (and unrelated) to overweight/obesity. We found that between 1995 and 2018, among individuals aged 60 years and older, PAF for overweight/obesity increased from 18% to 29% for all RCCs. In comparison, the PAF for smoking declined from 12% to 9%. RCC incidence increased 1.8% per year (95% confidence interval [CI] 1.5%‐2.1%) overall, while RCC incidence attributable to overweight/obesity increased 3.8% per year (95%CI 3.5%‐4.2%) and RCC incidence unrelated to overweight/obesity increased 1.2% per year (95% CI 0.9%‐1.4%). In conclusion, overweight/obesity appears to have contributed importantly to the rising incidence of RCC in the United States since the mid‐1990s. Public health interventions focused on reducing overweight and obesity could help substantially in curbing this trend. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
17. Association between type 2 diabetes and risk of cancer mortality: a pooled analysis of over 771,000 individuals in the Asia Cohort Consortium
- Author
-
Chen, Yu, Wu, Fen, Saito, Eiko, Lin, Yingsong, Song, Minkyo, Luu, Hung N., Gupta, Prakash C., Sawada, Norie, Tamakoshi, Akiko, Shu, Xiao-Ou, Koh, Woon-Puay, Xiang, Yong-Bing, Tomata, Yasutake, Sugiyama, Kemmyo, Park, Sue K., Matsuo, Keitaro, Nagata, Chisato, Sugawara, Yumi, Qiao, You-Lin, You, San-Lin, Wang, Renwei, Shin, Myung-Hee, Pan, Wen-Harn, Pednekar, Mangesh S., Tsugane, Shoichiro, Cai, Hui, Yuan, Jian-Min, Gao, Yu-Tang, Tsuji, Ichiro, Kanemura, Seiki, Ito, Hidemi, Wada, Keiko, Ahn, Yoon-Ok, Yoo, Keun-Young, Ahsan, Habibul, Chia, Kee Seng, Boffetta, Paolo, Zheng, Wei, Inoue, Manami, Kang, Daehee, and Potter, John D.
- Published
- 2017
- Full Text
- View/download PDF
18. Obesity at adolescence and gastric cancer risk
- Author
-
Song, Minkyo, Choi, Ji-Yeob, Yang, Jae Jeong, Sung, Hyuna, Lee, Yunhee, Lee, Hwi-Won, Kong, Seong-Ho, Lee, Hyuk-Joon, Kim, Hyung-Ho, Kim, Sang Gyun, Yang, Han-Kwang, and Kang, Daehee
- Published
- 2015
19. Associations of sleep duration with metabolic syndrome and its components in adult Koreans: from the Health Examinees Study
- Author
-
Yoon, Hyung-Suk, Lee, Kyoung-Mu, Yang, Jae Jeong, Lee, Hwi-Won, Song, Minkyo, Lee, Sang-Ah, Lee, Jong-koo, and Kang, Daehee
- Published
- 2016
- Full Text
- View/download PDF
20. Age and sex interactions in gastric cancer incidence and mortality trends in Korea
- Author
-
Song, Minkyo, Kang, Daehee, Yang, Jae Jeong, Choi, Ji-Yeob, Sung, Hyuna, Lee, Yunhee, Yoon, Hyung-Suk, Choi, Yunhee, Kong, Seong-Ho, Lee, Hyuk-Joon, Yang, Han-Kwang, and Kim, Woo Ho
- Published
- 2015
- Full Text
- View/download PDF
21. Prevalence of Participating in Physical Activity From 2 Korean Surveillance Systems: KNHANES and KCHS.
- Author
-
Park, JooYong, Shin, Aesun, Lee, Miyoung, Choi, Jaesung, Song, Minkyo, Kim, Yeonjung, Lee, Jong-koo, Kang, Daehee, and Choi, Ji-Yeob
- Subjects
PHYSICAL activity ,HEALTH behavior ,PHYSICAL fitness ,PREVENTIVE medicine ,PUBLIC health - Abstract
Background: This study aimed to estimate the prevalence and trends of participation in physical activity (PA) in Korean adults. Methods: The Korea National Health and Nutrition Examination Survey (KNHANES; 2009–2013) and the Korea Community Health Survey (KCHS; 2009–2013) were used to estimate the prevalence of PA. Age standardization was performed using population projections for Korea in 2005 as a standard population. Trends of the prevalence from 2009 to 2013 were assessed by joinpoint regression analysis. Results: The age-standardized prevalence for achieving the recommended level of PA was 63.0% in KNHANES and 64.5% in KCHS for men, and 53.7% in KNHANES and 56.3% in KCHS for women. Decreasing trends were observed for the prevalence of achieving the recommended level of PA in the KNHANES and KCHS; however, only the trend for women in KNHANES was statistically significant. Conclusions: Approximately, 60% of adults participate in the recommended level of PA in Korea. The survey design and characteristics should be considered when interpreting the prevalence of PA from different databases. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
22. Association of Serum High-Sensitivity C-Reactive Protein Level With the Risk of Site-Specific Cancer Mortality: The Health Examinees (HEXA) Study Cohort.
- Author
-
Lee, Sang-Ah, Kwon, Sung-Ok, Song, Minkyo, Choi, Ji-Yeob, Shin, Aesun, Shu, Xiao-Ou, Zheng, Wei, Lee, Jong-Koo, and Kang, Daehee
- Subjects
C-reactive protein ,RISK assessment ,SEX distribution ,DESCRIPTIVE statistics ,TUMORS ,DOSE-response relationship in biochemistry ,PROPORTIONAL hazards models ,LONGITUDINAL method - Abstract
Few studies have investigated the association between high-sensitivity C-reactive protein (hsCRP) level and site-specific cancer mortality. In this study, we aimed to examine the associations of hsCRP with overall and site-specific cancer mortality among South Koreans using data on the Health Examinees (HEXA) Study cohort (41,070 men and 81,011 women aged ≥40 years). We obtained mortality information from the National Statistical Office of Korea, which provided the dates and causes of all deaths occurring through December 31, 2015, by linking mortality data with each participant's unique national identifier. Cox proportional hazards and restricted cubic spline models were used to assess the association between hsCRP and cancer mortality with adjustment for covariates. An analysis of site-specific cancer mortality was focused on 5 major cancers (lung, liver, gastric, colorectal, and breast/prostate). Median hsCRP levels were 0.77 mg/L and 0.59 mg/L for men and women, respectively. A dose-response association between hsCRP and overall cancer mortality was observed in men but disappeared in women after exclusion of deaths occurring in the first 1 or 2 years of follow-up. Elevated hsCRP levels increased the risks of lung, liver, and gastric cancer mortality in men, but the risks of colorectal and breast cancer mortality were not increased. The dose-response association between hsCRP and cancer mortality was observed differently depending on site-specific cancer mortality by sex. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
23. Urinary estrogen metabolites and gastric cancer risk among postmenopausal women.
- Author
-
Camargo, M. Constanza, Song, Minkyo, Xu, Xia, Zhao, Isaac, Sampson, Joshua N., Etemadi, Arash, Brenner, Hermann, Lee, Hwi‐Won, Trabert, Britton, Holleczek, Bernd, Schöttker, Ben, Spaid, Kathleen, Dawsey, Sanford M., Lee, Sangjun, Shimura, Takaya, Park, Sue K., Malekzadeh, Reza, Kang, Daehee, and Rabkin, Charles S.
- Published
- 2022
- Full Text
- View/download PDF
24. The Potential Application of Personalized Preventive Research
- Author
-
Song, Minkyo, Lee, Hwi-Won, and Kang, Daehee
- Published
- 2014
- Full Text
- View/download PDF
25. Heterogeneity of epidemiological factors by breast tumor subtypes in Korean women: A case–case study
- Author
-
Song, Nan, Choi, Ji-Yeob, Sung, Hyuna, Chung, Seokang, Song, Minkyo, Park, Sue K., Han, Wonshik, Lee, Jong Won, Kim, Mi Kyung, Yoo, Keun-Young, Ahn, Sei-Hyun, Noh, Dong-Young, and Kang, Daehee
- Published
- 2014
- Full Text
- View/download PDF
26. Circulating immune- and inflammation-related biomarkers and early-stage noncardia gastric cancer risk.
- Author
-
Song, Minkyo, Rabkin, Charles S., Ito, Hidemi, Oze, Isao, Koyanagi, Yuriko N., Pfeiffer, Ruth M., Kasugai, Yumiko, Matsuo, Keitaro, and Camargo, M. Constanza
- Abstract
Background: In Helicobacter pylori -driven gastric cancer, mucosal colonization induces chronic inflammation that may variably progress to cancer. Prospective studies of circulating inflammation-related proteins have suggested weak associations with gastric cancer risk. To assess potential utility as a screening tool in clinical settings, we examined circulating levels of a wide range of key inflammation molecules for associations with early-stage gastric cancer. Methods: We used pretreatment EDTA plasma from 239 individuals with early-stage noncardia gastric cancer (203 stage I and 36 stage II) and 256 age-frequency-matched H. pylori -seropositive cancer-free controls within the Hospital-based Epidemiologic Research Program at Aichi Cancer Center. Levels of 92 biomarkers were measured by proximity extension assays using Olink's Proseek Immuno-oncology Panel. Odds ratios (ORs) for association with gastric cancer risk were calculated for quantiles (two to four categories) of each biomarker from unconditional logistic regression models, adjusted for age, sex, smoking and alcohol consumption. Two-sided P values <0.05 were considered as significant. The false discovery rate (FDR) was used to correct for multiple comparisons. Results: Of 83 evaluable biomarkers, lower levels of TNFRSF12A (per quartile OR, 0.82; nominal P -trend = 0.02) and ADGRG1 (per quartile OR, 0.84; nominal P -trend = 0.03) were associated with early-stage gastric cancer but were not statistically significant after FDR correction. Conclusion: Our study did not identify any inflammation-related biomarkers that may be useful for early disease detection. To date, this is the first assessment of circulating inflammation-related proteins in early-stage gastric cancer. Given the complex inflammation processes preceding malignant transformation, further investigation of other biomarkers is warranted. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
27. Associations Between Autoimmune Conditions and Gastric Cancer Risk Among Elderly Adults in the United States.
- Author
-
Song, Minkyo, Camargo, M. Constanza, Derkach, Andriy, Rabkin, Charles S., and Engels, Eric A.
- Subjects
- *
PERNICIOUS anemia , *CANCER risk factors , *AUTOIMMUNE diseases , *STOMACH cancer , *GASTRITIS , *CARCINOGENICITY - Abstract
INTRODUCTION: Pernicious anemia (PA) is a risk factor for gastric cancer. Other autoimmune conditions may also contribute. METHODS: In a case-control study, we evaluated 47 autoimmune conditions among 39,125 gastric cancers and 200,000 cancer-free controls. RESULTS: Six conditions were associated with increased gastric cancer risk (range of adjusted odds ratios: 1.28-1.93, P < 0.05): PA, membranous nephropathy, primary biliary cirrhosis, pure red cell aplasia, primary sclerosing cholangitis, and Graves disease. PA was associated with 8 other autoimmune conditions (adjusted odds ratios: 1.57-4.54, P < 0.05). DISCUSSION: Autoimmune conditions associated with gastric cancer or PA may reflect effects of autoimmune gastritis or other carcinogenic pathways. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
28. Obesity at early adulthood increases risk of gastric cancer from the Health Examinees-Gem (HEXA-G) study.
- Author
-
Lee, Hwi-Won, Huang, Dan, Shin, Woo-Kyoung, de la Torre, Katherine, Yang, Jae Jeong, Song, Minkyo, Shin, Aesun, Lee, Jong-koo, and Kang, Daehee
- Subjects
PROPORTIONAL hazards models ,STOMACH cancer ,DISEASE risk factors ,ADOLESCENT obesity ,ADULTS ,BODY mass index - Abstract
Emerging evidence has indicated a possible link between obesity in early life with subsequent cancer risks, but its association with gastric cancer remains unknown. This study aimed to investigate the association of obesity at ages 18–20 and 35 with the later risk of gastric cancer among the Korean population. Included were 122,724 individuals who participated in the large-scale prospective cohort study, the Health Examinees-Gem (HEXA-G) study, during 2004–2017. Multivariable Cox proportional hazards models were used to estimate hazard ratios (HR) and 95% confidence intervals (CI) for gastric cancer risk associated with body mass index (BMI) at ages 18–20 and 35 years. During a mean follow-up period of 8.6±2.1 years, a total 927 gastric cancer cases (531 men and 396 women) were identified. When compared to normal BMI (18.5–23.0 kg/m
2 ), obesity (BMI ≥30 kg/m2 ) at age 35 was significantly associated with increased risk of gastric cancer later in life among total participants (HR 1.94, 95% CI 1.26–2.97, p 0.01). When analyzed separately by sex, obesity at 35 years of age was significantly associated with increased risk of gastric cancer among both men (HR 1.79, 95% CI 1.02–3.13, p 0.05) and women (HR 2.35, 95% CI 1.21–4.60, p 0.02). No significant associations were found for obesity at late adolescence in both men and women. Our findings suggest that obesity in early adulthood may be associated with an increased risk of gastric cancer. The results may aid in understanding the etiology of GC in a population with a divergent trend of gastric cancer. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
29. Associations of Inflammatory Bowel Disease and Subsequent Cancers in a Population-Based Study of Older Adults in the United States.
- Author
-
Wang, Jeanny H, D'Arcy, Monica, Barnes, Edward L, Freedman, Neal D, Engels, Eric A, and Song, Minkyo
- Subjects
INFLAMMATORY bowel diseases ,CANCER risk factors ,ULCERATIVE colitis - Abstract
Background Cancer risk is elevated in patients with inflammatory bowel disease (IBD). A comprehensive investigation of cancer risk in older patients (≥66 years of age) is needed, because this understudied population is at high risk. Methods We performed a case-control study using Surveillance Epidemiology and End Results–Medicare data including 1 986 735 incident cancer cases (aged 66-99 years; diagnosed 1992-2015) and 200 000 controls matched by sex, age, race and ethnicity, and selection year. IBD was identified by ulcerative colitis (UC) or Crohn's disease (CD) diagnosis codes. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated with logistic regression, adjusting for potential confounders. For colorectal cancers, we further adjusted for screening rates. We assessed confounding by medication exposure among patients with prescription drug coverage. Results IBD, CD, and UC were present in 0.8%, 0.3%, and 0.5% in both cancer cases and non-cancer controls. Of 51 cancers examined, IBD was statistically significantly associated with cancers of the small intestine (OR = 2.55, 95% CI = 2.15 to 3.01), intrahepatic (OR = 1.92, 95% CI = 1.47 to 2.51) and extrahepatic bile ducts (OR = 1.75, 95% CI = 1.38 to 2.22), rectum (OR = 1.61, 95% CI = 1.36 to 1.90), and colon (OR = 1.21, 95% CI = 1.10 to 1.33). CD was associated with cancers of the small intestine (OR = 4.55, 95% CI = 3.65 to 5.67), and UC was associated with cancers of the intrahepatic bile ducts (OR = 1.87, 95% CI = 1.34 to 2.61), rectum (OR = 1.80, 95% CI = 1.47 to 2.20), and colon (OR = 1.28, 95% CI = 1.14 to 1.43). After adjusting for medication exposure, IBD was not statistically significantly associated with lung cancer, melanoma, diffuse large B-cell lymphoma, and myelodysplastic syndrome. Conclusions In this large study among older adults (≥66 years of age), IBD was positively associated with gastrointestinal cancers. Associations with extraintestinal cancers may reflect the effect of immunosuppressive medications. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
30. Association of Antiparietal Cell and Anti-Intrinsic Factor Antibodies With Risk of Gastric Cancer.
- Author
-
Song, Minkyo, Camargo, M. Constanza, Katki, Hormuzd A., Weinstein, Stephanie J., Männistö, Satu, Albanes, Demetrius, Surcel, Heljä-Marja, and Rabkin, Charles S.
- Published
- 2022
- Full Text
- View/download PDF
31. Breast Cancer Prevention Based on Gene–Environment Interaction
- Author
-
Song, Minkyo, Lee, Kyoung-Mu, and Kang, Daehee
- Published
- 2011
- Full Text
- View/download PDF
32. Circulating Levels of Sex Steroid Hormones and Gastric Cancer.
- Author
-
Leal, Yelda A., Song, Minkyo, Zabaleta, Jovanny, Medina-Escobedo, Gilberto, Caron, Patrick, Lopez-Colombo, Aurelio, Guillemette, Chantal, and Camargo, M. Constanza
- Subjects
- *
SEX hormones , *STOMACH cancer , *DISEASE risk factors , *MASS spectrometry , *TESTOSTERONE - Abstract
Men develop gastric cancer more frequently than women, yet little is known about the mechanisms underlying this sex difference. Sex steroid hormones may influence gastric cancer risk. We therefore assessed whether major circulating adrenal precursors, androgens and estrogens were associated with gastric cancer in a high-risk Mexican population. Blood samples were collected at time of diagnosis from 50 noncardia gastric cancer patients and 50 histologically confirmed non-atrophic gastritis controls. Serum levels of estradiol, testosterone and dehydroepiandrosterone (DHEA) measured with a validated mass spectrometry method were categorized in tertiles as low (T1), middle (T2), and high (T3). Unconditional logistic regression models were used to calculate odds ratios (ORs) and 95% confidence intervals (CI), adjusting for age, sex, and education. Levels of DHEA were inversely associated with gastric cancer (p -trend per tertile increase: <0.0001), with adjusted ORs (95% CI) of T2 and T3 (vs. T1) of 0.25 (0.09–0.70) and 0.10 (0.03–0.34), respectively. Levels of estradiol and testosterone were not significantly associated with gastric cancer. Our study provides evidence that higher concentration of circulating DHEA may be associated with lower risk of noncardia gastric cancer. Longitudinal studies are needed to evaluate the temporality of this association and investigate mechanisms of disease pathogenesis. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
33. The association between the preoperative serum levels of lipocalin-2 and matrix metalloproteinase-9 (MMP-9) and prognosis of breast cancer
- Author
-
Sung Hyuna, Choi Ji-Yeob, Lee Sang-Ah, Lee Kyoung-Mu, Han Sohee, Jeon Sujee, Song Minkyo, Lee Yunhee, Park Sue K, Yoo Keun-Young, Noh Dong-Young, Ahn Sei-Hyun, and Kang Daehee
- Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background Although a number of experimental studies have suggested the role of lipocalin-2 (LCN2) and matrix metalloproteinase-9 (MMP-9) in breast cancer progression, limited numbers of epidemiological studies have examined the relationship between the levels of lipocalin-2 and MMP-9 and breast cancer survival. Methods Preoperative serum levels of lipocalin-2 and MMP-9 were measured in 303 breast cancer patients and 74 healthy controls recruited between 2004 and 2007. We examined the association between lipocalin-2 and MMP-9 levels and disease-free survival (DFS) using Cox proportional hazard regression model. Results The serum levels of lipocalin-2 and MMP-9 were not significantly different between patients and controls (P > 0.05). Elevated lipocalin-2 and MMP-9 levels were associated with reduced DFS of breast cancer ( Ptrend = 0.029 and Ptrend = 0.063, respectively). When lipocalin-2 and MMP-9 levels were categorized based on the combined risk score, patients with higher levels of both lipocalin-2 and MMP-9 exhibited poor DFS compared to patients with lower levels (Ptrend = 0.004). Furthermore, these effects were profound in patients with BMI less than 25 kg/m2 (adjusted hazard ratio (aHR), 3.17; 95% confidence intervals (CI), 1.66-6.06, Ptrend Ptrend Conclusions Our study suggests that the elevated levels of lipocalin-2 and MMP-9 are associated with reduced breast cancer survival, particularly in patients with lower BMI and lymph-node negative breast cancers.
- Published
- 2012
- Full Text
- View/download PDF
34. Common genetic polymorphisms of microRNA biogenesis pathway genes and breast cancer survival
- Author
-
Sung Hyuna, Jeon Sujee, Lee Kyoung-Mu, Han Sohee, Song Minkyo, Choi Ji-Yeob, Park Sue K, Yoo Keun-Young, Noh Dong-Young, Ahn Sei-Hyun, and Kang Daehee
- Subjects
microRNA biogenesis pathway ,Breast cancer ,Survival ,Single nucleotide polymorphism ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background Although the role of microRNA’s (miRNA’s) biogenesis pathway genes in cancer development and progression has been well established, the association between genetic variants of this pathway genes and breast cancer survival is still unknown. Methods We used genotype data available from a previously conducted case–control study to investigate association between common genetic variations in miRNA biogenesis pathway genes and breast cancer survival. We investigated the possible associations between 41 germ-line single-nucleotide polymorphisms (SNPs) and both disease free survival (DFS) and overall survival (OS) among 488 breast cancer patients. During the median follow-up of 6.24 years, 90 cases developed disease progression and 48 cases died. Results Seven SNPs were significantly associated with breast cancer survival. Two SNPs in AGO2 (rs11786030 and rs2292779) and DICER1 rs1057035 were associated with both DFS and OS. Two SNPs in HIWI (rs4759659 and rs11060845) and DGCR8 rs9606250 were associated with DFS, while DROSHA rs874332 and GEMIN4 rs4968104 were associated with only OS. The most significant association was observed in variant allele of AGO2 rs11786030 with 2.62-fold increased risk of disease progression (95% confidence interval (CI), 1.41-4.88) and in minor allele homozygote of AGO2 rs2292779 with 2.94-fold increased risk of death (95% CI, 1.52-5.69). We also found cumulative effects of SNPs on DFS and OS. Compared to the subjects carrying 0 to 2 high-risk genotypes, those carrying 3 or 4–6 high-risk genotypes had an increased risk of disease progression with a hazard ratio of 2.16 (95% CI, 1.18- 3.93) and 4.47 (95% CI, 2.45- 8.14), respectively (P for trend, 6.11E-07). Conclusions Our results suggest that genetic variants in miRNA biogenesis pathway genes may be associated with breast cancer survival. Further studies in larger sample size and functional characterizations are warranted to validate these results.
- Published
- 2012
- Full Text
- View/download PDF
35. Helicobacter pylori Immunoproteomic Profiles in Gastric Cancer.
- Author
-
Song, Lusheng, Song, Minkyo, Rabkin, Charles S., Williams, Stacy, Chung, Yunro, Van Duine, Jennifer, Liao, Linda M., Karthikeyan, Kailash, Gao, Weimin, Park, Jin G., Tang, Yanyang, Lissowska, Jolanta, Qiu, Ji, LaBaer, Joshua, and Camargo, M. Constanza
- Published
- 2021
- Full Text
- View/download PDF
36. Association of sleep duration and quality with elevated hs-CRP among healthy Korean adults.
- Author
-
Lee, Hwi-Won, Yoon, Hyung-Suk, Yang, Jae Jeong, Song, Minkyo, Lee, Jong-koo, Lee, Sang-Ah, Choi, Ji-Yeob, and Kang, Daehee
- Subjects
SLEEP ,C-reactive protein ,LOGISTIC regression analysis ,ADULTS ,ODDS ratio - Abstract
This study aimed to investigate the association of sleep duration and quality with high-sensitivity C-reactive protein (hs-CRP) among middle-aged and elderly Koreans. Among a total of 74,867 participants (25,069 men and 49,798 women) recruited for the Health Examinees (HEXA) study, adjusted geometric means of hs-CRP level were compared across categories of sleep duration (<6, 6–7, 8–9, and ≥10 hours) and sleep quality (difficulty in initiating sleep and maintaining sleep) using ANCOVA models. Odds ratios (ORs) and 95% confidence intervals (CIs) for elevated hs-CRP (>3 mg/L) associated with sleep characteristics were estimated using multivariable-adjusted logistic regression models. Men who slept ≥10 hours per day were significantly associated with elevated hs-CRP (OR = 1.47, 95% CI 1.11–1.95). Whereas in women, difficulty in initiating sleep (OR = 1.28, 95% CI 1.04–1.57 for "Always"), and maintaining sleep was significantly associated with elevated hs-CRP levels (OR = 1.13, 95% CI 1.02–1.26 for "Often"; OR = 1.11, 95% CI 0.97–1.28 for "Always"). Additionally, women who experienced poor sleep quality presented an elevated level of hs-CRP (OR = 1.13, 95% CI 1.03–1.23). Our findings suggest that excessive sleep duration and poor sleep quality are significantly associated with the elevated inflammatory marker, specifically hs-CRP. Further research is needed to examine the effect of sleep interventions focused on these factors. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
37. Prediagnostic circulating inflammation biomarkers and esophageal squamous cell carcinoma: A case–cohort study in Japan.
- Author
-
Aversa, John, Song, Minkyo, Shimazu, Taichi, Inoue, Manami, Charvat, Hadrien, Yamaji, Taiki, Sawada, Norie, Pfeiffer, Ruth M., Karimi, Parisa, Dawsey, Sanford M., Rabkin, Charles S., Tsugane, Shoichiro, and Camargo, M. Constanza
- Subjects
SQUAMOUS cell carcinoma ,PROPORTIONAL hazards models ,EOSINOPHILIC esophagitis ,FALSE discovery rate ,BIOMARKERS ,HUMAN carcinogenesis ,ETIOLOGY of cancer - Abstract
Esophageal squamous cell carcinoma (ESCC) is the predominant histologic subtype of esophageal cancer worldwide. Measurements of circulating inflammation‐related biomarkers may inform etiology or provide noninvasive signatures for early diagnosis. We therefore examined levels of inflammation molecules for associations with ESCC risk. Using a case–cohort study designed within the Japan Public Health Center‐based Prospective Study, we measured baseline plasma levels of 92 biomarkers using a multiplex assay in a subcohort of 410 randomly selected participants and 66 participants with incident ESCC (including four cases that occurred in the subcohort). ESCC hazard ratios (HRs) were calculated for 2–4 quantiles of each biomarker by Cox proportional hazards regression models with age as the time metric, adjusted for sex, smoking and alcohol use. Twenty analytes were undetectable in nearly all samples. Of the remaining 72, 12 biomarkers (FGF19, ST1A1, STAMBP, AXIN1, CASP8, NT3, CD6, CDCP1, CD5, SLAMF1, OPG and CSF1) were associated with increased ESCC risk (ptrend < 0.05) with HRs per quantile 1.28–1.65. Seven biomarkers (CXCL6, CCL23, CXCL5, TGFA, CXCL1, OSM and CCL4) were inversely associated with HRs 0.57–0.72. FGF19, CASP8, STAMBP, ST1A1 and CCL‐4 met statistical significance with false discovery rate correction. Associations did not differ <5 vs. ≥5 years between blood collection and ESCC diagnosis. CASP8, STAMBP and ST1A1 were strongly correlated (p < 0.05). Our study expands the range of inflammation molecules associated with the development of this highly lethal neoplasia. Correlations among these novel biomarkers suggest a possible shared pathway. These findings need replication and could further delineate ESCCs molecular mechanisms of carcinogenesis. What's new?: Chronic inflammation has long been considered an important contributor to carcinogenesis. Circulating levels of inflammation‐related biomarkers may thus provide valuable information regarding cancer etiology, and may eventually aid in the early diagnosis of some cancers. In this study, the authors identified five such proteins that are associated with esophageal squamous cell carcinoma (ESCC) risk. These biomarkers may improve our understanding of ESCC etiology, enhance non‐invasive, molecular diagnostic panels, and may provide potential therapeutic targets. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
38. Associations of Viral Seroreactivity with AIDS-Related Non-Hodgkin Lymphoma.
- Author
-
Song, Minkyo, Bassig, Bryan A., Bender, Noemi, Goedert, James J., Winkler, Cheryl A., Brenner, Nicole, Waterboer, Tim, and Rabkin, Charles S.
- Abstract
Infection with human immunodeficiency virus (HIV) is associated with substantially increased incidence of non-Hodgkin lymphoma (NHL). This risk may be driven, in part, by reduced immune control over viral infections in the setting of acquired immunodeficiency syndrome (AIDS), although the lymphomagenic mechanisms are not yet established. We used bead-based multiplex assays to measure antibody seroreactivity to 32 viral antigens representing 22 different viral infections (human herpesviruses 1–8, hepatitis B and C virus, human T-lymphotropic virus type-1, and human polyomaviruses) in two prospective HIV cohorts. Incident (n = 28) and prevalent (n = 38) AIDS-related NHL cases were matched by age, sex, race, and CD4 count to 67 HIV-positive control individuals without AIDS-NHL. Logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for associations of AIDS-NHL with the number of different viruses to which an individual was seropositive and seroreactivity to individual antigens. Seropositivity to an increasing number of viruses was inversely associated with AIDS-NHL (OR per virus = 0.84, 95% CI = 0.72–0.98). Seroreactivity to herpes simplex virus 2 2mgG unique antigen (OR = 0.47; 95% CI = 0.23–0.97) and to WU polyomavirus viral capsid protein (OR = 0.26, 95% CI = 0.10–0.65) was significantly lower in AIDS-NHL cases compared to controls. In this evaluation of antibodies to multiple viruses, we observed an inverse association between seropositivity to a larger number of viruses and AIDS-NHL. While in need of further evaluation, our data raise the novel hypothesis that insufficient exposures or impaired humoral immune responses to viral infections may be associated with AIDS-related lymphomagenesis. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
39. HTLV-1 infection and health outcomes
- Author
-
Song, Minkyo, Piazuelo, Maria Blanca, and Camargo, Maria Constanza
- Published
- 2020
- Full Text
- View/download PDF
40. Autoimmune Diseases and Gastric Cancer Risk: A Systematic Review and Meta-Analysis.
- Author
-
Song, Minkyo, Latorre, Gonzalo, Ivanovic-Zuvic, Danisa, Camargo, M. Constanza, and Rabki, Charles S.
- Subjects
- *
GASTRIC diseases , *TYPE 1 diabetes , *STOMACH cancer , *AUTOIMMUNE diseases , *META-analysis - Abstract
Purpose Autoimmunity is an alternative etiology of gastric inflammation, the initiating event in the gastric carcinogenic cascade. This mechanism may be an increasingly important cause of gastric cancer with the waning prevalence of its primary etiologic factor, chronic Helicobacter pylori infection. Materials and Methods PubMed and EMBASE were searched up to September 2018. Autoimmunity and 96 specific manifestations were considered for associations with gastric cancer risk. Random effects analysis was used to calculate pooled relative risk estimates (RR) and 95% confidence intervals (CI). Results We found a total of 52 observational studies representing 30 different autoimmune diseases. Overall, the presence of an autoimmune condition was associated with a gastric cancer pooled RR of 1.37 (95% CI, 1.24 to 1.52). Among the 24 autoimmune conditions with two or more independent reports, nine were significantly associated with increased gastric cancer risk: dermatomyositis (RR, 3.69; 95% CI, 1.74 to 7.79), pernicious anemia (RR, 2.84; 95% CI, 2.30 to 3.50), Addison disease (RR, 2.11; 95% CI, 1.26 to 3.53), dermatitis herpetiformis (RR, 1.74; 95% CI, 1.02 to 2.97; n=3), IgG4-related disease (RR, 1.69; 95% CI, 1.00 to 2.87), primary biliary cirrhosis (RR, 1.64; 95% CI, 1.13 to 2.37), diabetes mellitus type 1 (RR, 1.41; 95% CI, 1.20 to 1.67), systemic lupus erythematosus (RR, 1.37; 95% CI, 1.01 to 1.84), and Graves disease (RR, 1.27; 95% CI, 1.06 to 1.52). Conclusion Our analysis documents the wide range of autoimmune diseases associated with gastric cancer. These associations may reflect unreported links between these conditions and autoimmune gastritis. Further studies are warranted to investigate potential causal mechanisms. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
41. Circulating inflammation‐related markers and advanced gastric premalignant lesions.
- Author
-
Song, Minkyo, Rabkin, Charles S, Hildesheim, Allan, Camargo, Maria Constanza, Torres, Javier, Kemp, Troy J, Pinto, Ligia A, Zabaleta, Jovanny, Sánchez‐Figueroa, Luz, Guarner, Jeannette, Herrera‐Goepfert, Roberto, and Parsonnet, Julie
- Subjects
- *
ATROPHIC gastritis , *PRECANCEROUS conditions , *HELICOBACTER pylori infections , *FALSE discovery rate , *HELICOBACTER pylori , *REGRESSION analysis - Abstract
Background and Aim: Chronic Helicobacter pylori infection causes gastric mucosal inflammation as an important antecedent of gastric cancer. We aimed to evaluate associations of blood markers of inflammation with gastric intestinal metaplasia and dysplasia in H. pylori‐infected individuals. Methods: We compared pre‐treatment serum levels of immune‐related and inflammation‐related markers between 99 individuals with intestinal metaplasia or dysplasia and 75 control individuals with non‐atrophic gastritis within an H. pylori eradication trial in Mexico. Serum levels of 28 markers measured with Luminex bead‐based assays were categorized in tertiles as low (T1), middle (T2), and high (T3). Logistic regression models were used to calculate age‐adjusted and sex‐adjusted odds ratios and 95% confidence intervals. All statistical tests were two‐sided, and significance values were adjusted for multiple comparisons using false discovery rate methods. Results: Five markers were nominally associated (Ptrend < 0.05) with the presence of advanced premalignant gastric lesions. Adjusted odds ratios (95% confidence interval) of T2 and T3 versus T1 were 4.09 (1.65–10.17) and 3.08 (1.23–7.68) for CCL3/MIP1A, 3.21 (1.33–7.75) and 2.69 (1.10–6.57) for CCL20/MIP3A levels, 1.79 (0.77–4.18) and 2.39 (1.02–5.60) for IL‐1β, 1.34 (0.56–3.19) and 3.02 (1.29–7.12) for IL‐4, and 1.07 (0.44–2.59) and 3.07 (1.32–7.14) for IL‐5, respectively. Two (IL‐4 and IL‐5) of the five markers had false discovery rate adjusted Ptrend < 0.2. Conclusions: Our results suggest that certain Th2 and other cytokines may have a role in promoting carcinogenesis in the setting of H. pylori infection. Additional research is needed to replicate these findings, extend to pre‐diagnostic samples, and elucidate the underlying mechanisms. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
42. Circulating inflammatory markers and colorectal cancer risk: A prospective case‐cohort study in Japan.
- Author
-
Song, Minkyo, Sasazuki, Shizuka, Camargo, M. Constanza, Shimazu, Taichi, Charvat, Hadrien, Yamaji, Taiki, Sawada, Norie, Kemp, Troy J., Pfeiffer, Ruth M., Hildesheim, Allan, Pinto, Ligia A., Rabkin, Charles S., and Tsugane, Shoichiro
- Abstract
Blood levels of inflammation‐related markers may reveal molecular pathways contributing to carcinogenesis. To date, prospective associations with colorectal cancer (CRC) risk have been based on few studies with limited sets of analytes. We conducted a case‐cohort study within the Japan Public Health Center‐based Prospective Study Cohort II, comparing 457 incident CRC cases during median 18 years follow‐up with a random subcohort of 774 individuals. Baseline plasma levels of 62 cytokines, soluble receptors, acute‐phase proteins, and growth factor markers were measured using Luminex bead‐based assays. We estimated hazard ratios (HRs) associating each marker with CRC risk by Cox proportional hazards models adjusted for potential confounders. Subanalyses compared cases by years after blood draw (<5 vs. ≥5) and anatomical subsite (colon vs. rectum). Linear trends in quantiles of four C‐C motif ligand (CCL) chemokines, one C‐X‐C motif ligand (CXCL) chemokine, and a soluble receptor were nominally associated with CRC risk based on ptrend < 0.05, but none met false discovery rate corrected statistical significance. HRs for the 4th vs. 1st quartile were: 1.69 for CCL2/MCP1, 1.61 for soluble tumor necrosis factor receptor 2, 1.39 for CCL15/MIP1D, 1.35 for CCL27/CTACK, 0.70 for CXCL6/GCP2 and 0.61 for CCL3/MIP1A. Among cases diagnosed 5+ years after enrollment, CCL2/MCP1, CCL3/MIP1A and CXCL6/GCP2 retained nominal statistical significance. There were no significant differences in associations between colon and rectum. Our findings implicate chemokine alterations in colorectal carcinogenesis, but require replication for confirmation. Noninvasive chemokine assays may have potential application in colorectal cancer screening and etiologic research. What's new? Chronic inflammatory bowel diseases are known risk factors for colorectal cancer (CRC) but few prospective studies with limited sets of markers have investigated the association of circulating inflammatory markers and CRC risk. Here the authors performed a comprehensive analysis of 62 circulating markers and identified five chemokines associated with CRC risk. No differences between colon and rectum cancers were observed suggesting that tests for these chemokines may be useful screening tools for both colon and rectal cancers. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
43. Tu1294 - Helicobacter Pylori Immunoproteomic Profiles in Patients with Gastric Cancer
- Author
-
Song, Lusheng, Song, Minkyo, Rabkin, Charles S., Van Duine, Jennifer, Liao, Linda, Karthikeyan, Kailash, Gao, Weimin, Lissowska, Jolanta, Qiu, Ji, LaBaer, Joshua, and Camargo, M. Constanza
- Published
- 2018
- Full Text
- View/download PDF
44. Su1236 - Circulating Inflammation-Related Markers and Advanced Gastric Premalignant Lesions
- Author
-
Song, Minkyo, Rabkin, Charles S., Torres, Javier, Kemp, Troy J., Zabaleta, Jovanny, Pinto, Ligia A., Hildesheim, Allan, Sánchez-Figueroa, Luz, Guarner, Jeannette, Herrera-Goepfert, Roberto, Parsonnet, Julie, and Camargo, Maria C.
- Published
- 2018
- Full Text
- View/download PDF
45. Electronic Alerts with Automated Consultations Promote Appropriate Antimicrobial Prescriptions.
- Author
-
Kim, Moonsuk, Song, Kyoung-Ho, Kim, Chung-Jong, Song, Minkyo, Choe, Pyoeng Gyun, Park, Wan Beom, Bang, Ji Hwan, Hwang, Hee, Kim, Eu Suk, Park, Sang-Won, Kim, Nam Joong, Oh, Myoung-don, and Kim, Hong Bin
- Subjects
ANTI-infective agents ,DRUG prescribing ,MICROBIAL sensitivity tests ,MEDICAL consultation ,AUTOMATION ,MEDICAL electronics - Abstract
Background: To promote appropriate antimicrobial use in bloodstream infections (BSIs), we initiated an intervention program consisting of electronic alerts and automated infectious diseases consultations in which the identification and antimicrobial susceptibility test (ID/AST) results were reported. Methods: We compared the appropriateness of antimicrobial prescriptions and clinical outcomes in BSIs before and after initiation of the program. Appropriateness was assessed in terms of effective therapy, optimal therapy, de-escalation therapy, and intravenous to oral switch therapy. Results: There were 648 BSI episodes in the pre-program period and 678 in the program period. The proportion of effective, optimal, and de-escalation therapies assessed 24 hours after the reporting of the ID/AST results increased from 87.8% (95% confidence interval [CI] 85.5–90.5), 64.4% (95% CI 60.8–68.1), and 10.0% (95% CI 7.5–12.6) in the pre-program period, respectively, to 94.4% (95% CI 92.7–96.1), 81.4% (95% CI 78.4–84.3), and 18.6% (95% CI 15.3–21.9) in the program period, respectively. Kaplan-Meier analyses and log-rank tests revealed that the time to effective (p<0.001), optimal (p<0.001), and de-escalation (p = 0.017) therapies were significantly different in the two periods. Segmented linear regression analysis showed the increase in the proportion of effective (p = 0.015), optimal (p<0.001), and de-escalation (p = 0.010) therapies at 24 hours after reporting, immediately after program initiation. No significant baseline trends or changes in trends were identified. There were no significant differences in time to intravenous to oral switch therapy, length of stay, and 30-day mortality rate. Conclusion: This novel form of stewardship program based on intervention by infectious disease specialists and information technology improved antimicrobial prescriptions in BSIs. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
46. What Are the Major Determinants in the Success of Smoking Cessation: Results from the Health Examinees Study.
- Author
-
Yang, Jae Jeong, Song, Minkyo, Yoon, Hyung-Suk, Lee, Hwi-Won, Lee, Yunhee, Lee, Sang-Ah, Choi, Ji-Yeob, Lee, Jong-koo, and Kang, Daehee
- Subjects
- *
SMOKING cessation , *PERIODIC health examinations , *ACADEMIC achievement , *REGRESSION analysis , *TOBACCO - Abstract
Understanding mechanisms underlying smoking-related factors should be prioritized in establishing smoking prevention and cessation policy. The aim of this study was to identify factors significantly associated with smoking initiation and/or smoking cessation as well as the most important determinants of successful smoking cessation in a developed non-Western setting. Based on multiple logistic regression models, the odds ratios (ORs) for smoking initiation and cessation were estimated among males (N = 24,490) who had participated in the Health Examinees (HEXA) study. The Cox proportional hazards regression model was used to assess the association between selected predictors of smoking cessation and the likelihood of reaching this goal. Finally, Kaplan–Meier curves were constructed to illustrate the distribution of time from age at smoking initiation to age at smoking cessation. We found that the ORs for successfully quitting smoking increased with age, married status, educational achievement, having a non-manual job, drinking cessation and disease morbidity. Those exposed to secondhand smoking showed less likelihood of quitting smoking. A continual decrease in the ORs for successfully quitting smoking was observed according to increased smoking duration, smoking dose per day and lifetime tobacco exposure (ptrend <0.001). Among the selected predictors, lifetime tobacco exposure, educational attainment, alcohol drinking status and birth cohort were the major determinants in the success of smoking cessation. Our findings suggest that lifetime tobacco exposure, educational attainment, alcohol drinking status and birth cohort can determine success in smoking cessation. Public interventions promoting a smoke-free environment are needed to reinforce discouraging the initiation of, reducing, and quitting cigarette smoking. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
47. Determinants of Poor Self-rated Health in Korean Adults With Diabetes.
- Author
-
Hwi-Won Lee, Minkyo Song, Jae Jeong Yang, Daehee Kang, Lee, Hwi-Won, Song, Minkyo, Yang, Jae Jeong, and Kang, Daehee
- Published
- 2015
- Full Text
- View/download PDF
48. Response to Liu and Zhou.
- Author
-
Song, Minkyo and Engels, Eric A.
- Subjects
- *
EAST Asians , *STOMACH cancer - Abstract
We did not examine autoimmune pancreatitis (AIP) in our study, but Liu and Zhou highlight the potential role of this condition as a cause of gastric cancer, especially in Eastern Asia. We thank Liu and Zhou for their comments ([1]) regarding our recent publication investigating associations between autoimmune diseases and gastric cancer in older adults in the United States ([2]). However, other studies of AIP and gastric cancer did not report measures of association, including the 3 studies ([[3], [6]]), Liu and Zhou referenced in their letter ([1]). [Extracted from the article]
- Published
- 2022
- Full Text
- View/download PDF
49. Correlates of Self-Reported Sleep Duration in Middle-Aged and Elderly Koreans: from the Health Examinees Study.
- Author
-
Yoon, Hyung-Suk, Yang, Jae Jeong, Song, Minkyo, Lee, Hwi-Won, Han, Sohee, Lee, Sang-Ah, Choi, Ji-Yeob, Lee, Jong-koo, and Kang, Daehee
- Subjects
SELF-evaluation ,HEALTH ,SLEEP ,HEALTH of middle-aged persons ,HEALTH of older people ,PERIODIC health examinations ,POPULATION biology - Abstract
Though various factors related to fluctuations in sleep duration have been identified, information remains limited regarding the correlates of short and long sleep duration among the Korean population. Thus, we investigated characteristics that could be associated with short and/or long sleep duration among middle-aged and elderly Koreans. A total of 84,094 subjects (27,717 men and 56,377 women) who participated in the Health Examinees Study were analyzed by using multinomial logistic regression models. To evaluate whether sociodemographic factors, lifestyle factors, psychological conditions, anthropometry results, and health conditions were associated with short and/or long sleep duration, odds ratios (ORs) and 95% confidence intervals (CIs) were estimated with sleep duration of 6–7 hours as the reference group, accounting for putative covariates. Regardless of sexual differences, we found that adverse behaviors and lifestyle factors including low educational attainment, unemployment, being unmarried, current smoking status, lack of exercise, having irregular meals, poor psychosocial well-being, frequent stress events, and poor self-rated health were significantly associated with abnormal sleep duration. Similarly, diabetes mellitus and depression showed positive associations with abnormal sleep duration in both men and women. Our findings suggest that low sociodemographic characteristics, adverse lifestyle factors, poor psychological conditions, and certain disease morbidities could be associated with abnormal sleep duration in middle-aged and elderly Koreans. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
50. Tumor Subtype-Specific Associations of Hormone-Related Reproductive Factors on Breast Cancer Survival.
- Author
-
Song, Nan, Choi, Ji-Yeob, Sung, Hyuna, Jeon, Sujee, Chung, Seokang, Song, Minkyo, Park, Sue K., Han, Wonshik, Lee, Jong Won, Kim, Mi Kyung, Yoo, Keun-Young, Ahn, Sei-Hyun, Noh, Dong-Young, and Kang, Daehee
- Subjects
BREAST cancer risk factors ,DISEASE incidence ,ESTROGEN ,MENSTRUAL cycle ,BREASTFEEDING ,HORMONE receptors - Abstract
Purpose: It is inconclusive whether reproductive factors, which are known as risk factors of breast cancer, also influence survival. We investigated overall and subtype-specific associations between reproductive factors and breast cancer survival. Methods: Among 3,430 incident breast cancer patients who enrolled in the Seoul Breast Cancer Study, 269 patients (7.8%) died and 528 patients (15.4%) recurred. The overall and subtype-specific associations of reproductive factors including age at menarche and menopause, duration of estrogen exposure, menstrual cycle, parity, age at first full-term pregnancy, number of children, age at last birth, time since the last birth, and duration of breastfeeding, on overall and disease-free survival (OS and DFS) were estimated by hazard ratios (HRs) and 95% confidence intervals (95% CIs) using a multivariate Cox proportional hazard model. Results: An older age at menarche (HR for OS=1.10, 95% CI=1.03-1.19), a greater number of children (≥4 vs. 2, HR for DFS=1.58, 95% CI=1.11-2.26), and a shorter time since last birth (<5 vs. ≥20 years, HR for DFS=1.67, 95% CI=1.07-2.62) were associated with worse survival while longer duration of estrogen exposure with better survival (HR for DFS=0.97, 95% CI=0.96-0.99). In the stratified analyses by subtypes, those associations were more pronounced among women with hormone receptor and human epidermal growth factor 2 positive (HR+ HER2+) tumors. Conclusions: It is suggested that reproductive factors, specifically age at menarche, number of children, time since last birth, and duration of estrogen exposure, could influence breast tumor progression, especially in the HR+ HER2+ subtype. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.